Efficacy of tryushnadya churna in metabolic syndrome with obesity - A randomized double blind controlled clinical trial

被引:0
|
作者
Chandake, Soujanya [1 ]
Tubaki, Basavaraj R. [2 ]
Gonugade, Varsha [2 ]
Sharma, Oshin [2 ]
机构
[1] Dr Basavaraj Nagur Mem Ayurved Med Coll, Dept Kaumarbhrutya, Vijayapura, Karnataka, India
[2] Shri BMK Ayurveda Mahavidyalaya, KLE Acad Higher Educ & Res, Dept Kayachikitsa, Constituent Unit, Belagavi, Karnataka, India
关键词
Ayurveda; Metabolic syndrome; Obesity; Tryushnadi churna; Ayurveda diet; Yoga; LIFE-STYLE INTERVENTION; SKINFOLD-THICKNESS; ABDOMINAL OBESITY; GLYCEMIC INDEX; BLOOD-PRESSURE; YOUNG-ADULTS; RISK-FACTORS; BODY-FAT; DIET; MANAGEMENT;
D O I
10.1016/j.jaim.2024.100973
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Metabolic syndrome (MetS) with obesity has significant mortality and morbidity. Integrative Ayurveda management is explored for it's possible effect. Aim: To evaluate the effect of Tryushnadi churna in the management of Metabolic syndrome with obesity. Methods: Study is a Randomized, Controlled, double blind, parallel group comparative clinical trial. 48 participants meeting the National Cholesterol Education Programme Adult Treatment panel 3 diagnostic criteria were recruited in the study. They were divided in two 2 groups. Placebo group were administered with Placebo 1 gm twice a day, Ayurveda diet and yoga. Tryushnadi Group were intervened with Tryushnadi churna 1 gm twice a day, Ayurveda diet and yoga. Interventions were for 90 days. Assessments criteria included Weight, BMI,Waist circumference (WC), Waist hip ratio, Skin fold thickness (SFT), Body fat, blood pressure, WHO-QOL BREF scale, Clinical Global Impression Scale (CGI)- Severity, Global improvement and Efficacy index, Fasting blood sugar (FBS) were assessed on every 30th day. Other blood parameters like Glycated haemoglobin (HbA1c), Triglycerides, High density lipoproteins (HDL), Low density lipoproteins (LDL), Total cholesterol (TC) were evaluated at pre and post study. Results: Between groups comparison showed, Tryushnadi group had significant improvements in BMI, Weight, WHOQOL-Bref and had large effect size. Both the groups showed improvement in WC, body fat, SFT, CGI severity, CGI efficacy index and improvement in quality of life in within group assessment. Conclusion: Study showed that Tryushnadi churna was effective in management of MetS with Obesity. Integrated management of Ayurveda medicine, Ayurveda diet and yoga had beneficial effect.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Evaluation of Menopausal Syndrome Relief and Anti-Obesity Efficacy of the Korean Fermented Food Doenjang: A Randomized, Double-Blind Clinical Trial
    Han, A. Lum
    Ryu, Myeong Seon
    Yang, Hee-Jong
    Jeong, Do-Youn
    Choi, Keum Ha
    NUTRIENTS, 2024, 16 (08)
  • [32] The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial
    Holka-Pokorska, Justyna
    Radzio, Rafal
    Jarema, Marek
    Wichniak, Adam
    PSYCHIATRIA POLSKA, 2015, 49 (02) : 363 - 376
  • [33] The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alidadi, Mona
    Sahebkar, Amirhossein
    Eslami, Saeid
    Vakilian, Farveh
    Jarahi, Lida
    Alinezhad-Namaghi, Maryam
    Arabi, Seyed Mostafa
    Vakili, Saba
    Tohidinezhad, Fariba
    Nikooiyan, Yasaman
    Norouzy, Abdolreza
    PHARMACOLOGICAL PROPERTIES OF PLANT-DERIVED NATURAL PRODUCTS AND IMPLICATIONS FOR HUMAN HEALTH, 2021, 1308 : 1 - 11
  • [34] Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial
    Song, Eun-Ji
    Han, Kyungsun
    Lim, Tae-Joong
    Lim, Sanghyun
    Chung, Myung-Jun
    Nam, Myung Hee
    Kim, Hojun
    Nam, Young-Do
    EPMA JOURNAL, 2020, 11 (01) : 31 - 51
  • [35] Evaluation of a Supervised Adapted Physical Activity Program Associated or Not with Oral Supplementation with Arginine and Leucine in Subjects with Obesity and Metabolic Syndrome: A Randomized Controlled Trial
    Folope, Vanessa
    Meret, Caroline
    Castres, Ingrid
    Tourny, Claire
    Houivet, Estelle
    Grigioni, Sebastien
    Lelandais, Helene
    Petit, Andre
    Coquard, Aude
    Guerin, Charlene
    Quillard, Muriel
    Bole-Feysot, Christine
    Dechelotte, Pierre
    Achamrah, Najate
    Coeffier, Moise
    NUTRIENTS, 2022, 14 (18)
  • [36] Blueberries Improve Endothelial Function, but Not Blood Pressure, in Adults with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Stull, April J.
    Cash, Katherine C.
    Champagne, Catherine M.
    Gupta, Alok K.
    Boston, Raymond
    Beyl, Robbie A.
    Johnson, William D.
    Cefalu, William T.
    NUTRIENTS, 2015, 7 (06) : 4107 - 4123
  • [37] Effects of ginger supplementation on anthropometric, glycemic and metabolic parameters in subjects with metabolic syndrome: A randomized, double-blind, placebo-controlled study
    Rahimlou, Mehran
    Yari, Zahra
    Rayyani, Elham
    Keshavarz, Seyed Ali
    Hosseini, Seyedahmad
    Morshedzadeh, Nava
    Hekmatdoost, Azita
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2019, 18 (01) : 119 - 125
  • [38] Metformin for overweight women at midlife: a double-blind, randomized, controlled trial
    Worsley, R.
    Jane, F.
    Robinson, P. J.
    Bell, R. J.
    Davis, S. R.
    CLIMACTERIC, 2015, 18 (02) : 270 - 277
  • [39] Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial
    Salehifar, Ebrahim
    Azimi, Saeid
    Janbabai, Ghasem
    Zaboli, Ehsan
    Hendouei, Narjes
    Saghafi, Fatemeh
    Borhani, Samaneh
    BMC CANCER, 2020, 20 (01)
  • [40] Efficacy of a dietary supplement in dogs with osteoarthritis: A randomized placebo-controlled, double-blind clinical trial
    Martello, Elisa
    Bigliati, Mauro
    Adami, Raffaella
    Biasibetti, Elena
    Bisanzio, Donal
    Meineri, Giorgia
    Bruni, Natascia
    PLOS ONE, 2022, 17 (02):